Cent Eur J Public Health 2021, 29(2):96-101 | DOI: 10.21101/cejph.a6124

Evaluation of effectiveness of pathology reports in active surveillance of tuberculosis

Özlem Terzi1, Derya Öztomurcuk2, Seda Gün3, Zeki Kiliçaslan4
1 Department of Public Health, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
2 TB Provincial Coordination Office, Samsun, Turkey
3 Department of Pathology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey
4 Department of Chest Diseases, Medical Faculty, Istanbul University, Istanbul, Turkey

Objective: Despite advancing technology, national TB surveillance systems are still inadequate in terms of patient detection around the world. It was aimed to investigate suspicious cases detected by active surveillance method in pathology laboratories and to evaluate the effectiveness of this method in terms of finding new TB cases.

Methods: This is a descriptive cross-sectional study. It was administrated in Samsun, Turkey, between January 2012-December 2017. Within the scope of active surveillance, pathology laboratories were regularly visited and reported cases with granulomatous inflammation were assessed. The obtained patient list was compared with the records of the Electronic Tuberculosis Management System (ETMS). Patients who were not included in these records were invited to the dispensary and evaluated for TB. They were also referred to the relevant hospitals for diagnosis if necessary. Frequency values and descriptive statistics were calculated using SPSS method.

Results: It was found that 35.6% of 703 patients with the diagnosis of granulomatous inflammation were previously diagnosed, treated or currently undergoing treatment in the ETMS registry. As a result of the assessment of remaining 453 cases, 46 patients (10.1%) were newly diagnosed with TB. Newly diagnosed TB patients were reported, and their treatment started.

Conclusion: As a result, active surveillance method conducted in pathology laboratories are used to detect unknown or late reported TB cases and allows to start treatment without further delay.

Keywords: tuberculosis, granulomatous inflammation, active surveillance

Received: February 4, 2020; Revised: January 25, 2021; Accepted: January 25, 2021; Published: June 30, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Terzi Ö, Öztomurcuk D, Gün S, Kiliçaslan Z. Evaluation of effectiveness of pathology reports in active surveillance of tuberculosis. Cent Eur J Public Health. 2021;29(2):96-101. doi: 10.21101/cejph.a6124. PubMed PMID: 34245548.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. World Health Organization. Global tuberculosis report 2019 [Internet]. Geneva: WHO; 2019 [cited 2021 Jan 10]. Available from: https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf.
    2. Curtis AB, McCray E, McKenna M, Onorato IM. Completeness and timeliness of tuberculosis case reporting: a multistate study. Am J Prev Med. 2001;20(2):108-12. Go to original source... Go to PubMed...
    3. Tollefson D, Ngari F, Mwakala M, Gethi D, Kipruto H, Cain K, et al. Under-reporting of sputum smear-positive tuberculosis cases in Kenya. Int J Tuberc Lung Dis. 2016;20(10):1334-41. Go to original source... Go to PubMed...
    4. World Health Organization. WHO recommended surveillance standards. 2nd ed. [Internet]. Geneva: WHO; 1999 [cited 2021 Jan 10]. Available from: http://apps.who.int/iris/handle/10665/65517.
    5. Ghosh S, Moonan PK, Cowan L, Grant J, Kammerer S, Navin TR. Tuberculosis genotyping information management system: enhancing tuberculosis surveillance in the United States. Infect Genet Evol. 2012;12(4):782-8. Go to original source... Go to PubMed...
    6. Silva GDMD, Bartholomay P, Cruz OG, Garcia LP. Evaluation of data quality, timeliness and acceptability of the tuberculosis surveillance system in Brazil's micro-regions. Cien Saude Colet. 2017 Oct;22(10):3307-19. Go to original source... Go to PubMed...
    7. Migliori GB, Spanevello A, Ballardini L, Neri M, Gambarini C, Moro ML, et al; Varese Tuberculosis Study Group. Validation of the surveillance system for new cases of tuberculosis in a province of northern Italy. Eur Respir J. 1995 Aug;8(8):1252-8. Go to original source... Go to PubMed...
    8. Romero ROG, Ribeiro CMC, Sá LD, Villa TCS, Nogueira J de A. Underreporting of tuberculosis cases from death surveillance. Rev Eletr Enferm [Internet]. 2016 Jun 30 [cited 2021 Jan 25];18. Available from: https://revistas.ufg.br/fen/article/view/37249. Go to original source...
    9. Solovic I, Jonsson J, Korzeniewska-Kose³a M, Chiotan DI, Pace-Asciak A, Slump E, et al. Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011. Euro Surveill. 2013 Mar 21;18(12). pii: 20432. Go to original source...
    10. Report on tuberculosis in Turkey, 2019 [Internet]. Ankara: HSGM; 2020 [cited 2021 Jan 10]. Available from: https://hsgm.saglik.gov.tr/tr/tuberkuloz-haberler/turkiye-de-verem-savas-2019-raporu.html. (In Turkish.)
    11. Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis. 2003;3(5):288-96. Go to original source... Go to PubMed...
    12. Driver CR, Braden CR, Nieves RL, Navarro AM, Rullan JV, Valway SE, et al. Completeness of tuberculosis case reporting, San Juan and Caguas Regions, Puerto Rico, 1992. Public Health Rep. 1996;111(2):157-61.
    13. San Gabriel P, Saiman L, Kaye K, Silin M, Onorato I, Schulte J. Completeness of pediatric TB reporting in New York City. Public Health Rep. 2003;118(2):144-53. Go to original source... Go to PubMed...
    14. Lai S, Wangteeraprasert T, Sermkaew T, Nararak O, Binsard S, Phanawadee M, et al. Evaluation of three main tuberculosis case reporting systems in Satun Province, Thailand, 2011. Outbreak Surveill Investig Rep [Internet]. 2014 [cited 2021 Jan 25];7(3):16-23. Available from: http://www.osirjournal.net/index.php/osir/article/view/37.
    15. Mukhopadhyay S, Farver CF, Vaszar LT, Dempsey OJ, Popper HH, Mani H, et al. Causes of pulmonary granulomas: a retrospective study of 500 cases from seven countries. J Clin Pathol. 2012;65(1):51-7. Go to original source... Go to PubMed...
    16. McAdam AJ, Sharpe AH. Infectious diseases. In: Kumar V, Abbas AK, Aster JC, editors. Robbins and Cotran pathologic basis of disease. 9th ed. Philadelphia: Elsevier/Saunders; 2015. p. 371-6.
    17. Türkkani MH, Özdemir T, Akkuº İH. Should tuberculosis reporting be done from the laboratories? J Izmir Chest Hosp. 2019;33(3):145-51. (In Turkish.)
    18. Türkkani MH, Koyuncu E, Özkara S, Güneri FD, Özdemir T. The Problems about the Management of Tuberculosis Control Program for the Patients with Vertebral Tuberculosis. Solunum Hast Derg. 2015;25 (2-3):11-6. (In Turkish.)
    19. Kara F, editor. Tuberculosis active surveillance criteria. 2nd ed. [Internet]. Ankara: Ministry of Health, Turkey; 2019 [cited 2021 Jan 10]. Available from: https://hsgm.saglik.gov.tr/depo/birimler/tuberkuloz_db/haberler/Tuberkuloz_Tani_Ve_Tedavi_Rehberi_/Tuberkuloz_Tani_ve_Tedavi_Rehberi.pdf. (In Turkish.)
    20. Mukhopadhyay S. Non-neoplastic pulmonary pathology: an algorithmic approach to histologic findings in the lung. Cambridge: Cambridge University Press; 2016.
    21. Jain D, Ghosh S, Teixeira L, Mukhopadhyay S. Pathology of pulmonary tuberculosis and non-tuberculous mycobacterial lung disease: facts, misconceptions, and practical tips for pathologists. Semin Diagn Pathol. 2017 Nov;34(6):518-29. Go to original source... Go to PubMed...
    22. Yone EW, Kengne AP, Moifo B, Kuaban C. Prevalence and determinants of extrapulmonary involvement in patients with pulmonary tuberculosis in a Sub-Saharan African country: a cross-sectional study. Scand J Infect Dis. 2013 Feb;45(2):104-11. Go to original source... Go to PubMed...
    23. Mukhopadhyay S, Gal AA. Granulomatous lung disease: an approach to the differential diagnosis. Arch Pathol Lab Med. 2010;134(5):667-90. Go to original source... Go to PubMed...
    24. Park DY, Kim JY, Choi KU, Lee JS, Lee CH, Sol MY, et al. Comparison of polymerase chain reaction with histopathologic features for diagnosis of tuberculosis in formalin-fixed, paraffin-embedded histologic specimens. Arch Pathol Lab Med. 2003;127(3):326-30. Go to original source... Go to PubMed...
    25. Pillaye J, Clarke A. An evaluation of completeness of tuberculosis notification in the United Kingdom. BMC Public Health. 2003 Oct 6;3:31. doi: 10.1186/1471-2458-3-31. Go to original source... Go to PubMed...
    26. World Health Organization. Global tuberculosis control: WHO report 2001. Geneva: WHO; 2001.
    27. World Health Organization. WHO TB surveillance checklist [Internet]. Geneva: WHO; 2013 [cited 2021 Jan 10]. Available from: http://www.who.int/tb/meetings/accra.
    28. Lönnroth K, Migliori GB, Abubakar I, D'Ambrosio L, De Vries G, Diel R, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J. 2015;45(4):928-52. Go to original source... Go to PubMed...
    29. Satpati M, Burugina Nagaraja S, Shewade HD, Aslesh PO, Samuel B, Khanna A, et al. TB notification from private health sector in Delhi, India: challenges encountered by programme personnel and private health care providers. Tuberc Res Treat. 2017;2017:6346892. doi: 10.1155/2017/6346892. Go to original source... Go to PubMed...
    30. Van der Werf MJ, Sotgiu G, Dara M. Closing the gap in surveillance of tuberculosis and HIV co-infection: a European perspective on the need for clinician-public health alliances. Eur Respir J. 2017 Nov 16;50(5):1701758. doi: 10.1183/13993003.01758-2017. Go to original source... Go to PubMed...
    31. Norbis L, Alagna R, Tortoli E, Codecasa LR, Migliori GB, Cirillo DM. Challenges and perspectives in the diagnosis of extrapulmonary tuberculosis. Expert Rev Anti Infect Ther. 2014;12(5):633-47. Go to original source... Go to PubMed...
    32. Kang W, Yu J, Du J, Yang S, Chen H, Liu J, et al. The epidemiology of extrapulmonary tuberculosis in China: a large-scale multi-center observational study. PLoS One. 2020;15(8):e0237753. doi: 10.1371/journal.pone.0237753. Go to original source... Go to PubMed...
    33. Theron G, Jenkins HE, Cobelens F, Abubakar I, Khan AJ, Cohen T, et al. Data for action: collection and use of local data to end tuberculosis. Lancet. 2015;386(10010):2324-33. Go to original source... Go to PubMed...
    34. Zumla A, George A, Sharma V, Herbert RH, Oxley A, Oliver M. The WHO 2014 global tuberculosis report - further to go. Lancet Glob Health. 2015 Jan;3(1):e10-2. Go to original source... Go to PubMed...

    Return to the content